Research means finding answers to questions.​

The questions that we concern ourselves with arise from our everyday work in our practice. The search for answers aims to constantly continue the development of the active-specific immunotherapy against cancer and to make the results of our research generally accessible.

 

The purpose of the IOZK Foundation is to develop the scientific basis of immuno-oncological research and its translation into practice. The measures aim to promote the research of therapy options against cancer and the swift implementation of their results into patient care in accordance with regulatory guidelines.

HOME

IOZK FOUNDATION NEWS​

Two T cells on a cancer cell, scanning electron microscopy, Steve Gschmeissner/Science Photo.

Research means finding answers to questions.​

In our magazine IOZK Consilium and our brochure you will find more information about the scientific background of our cancer therapy.

PROF. DR. SCHIRRMACHER, SYMPOSIUM KIEL, APRIL 2019

 

Prof. Dr. Schirrmacher opened the Kiel Oncology Network Symposium on tumour immunology. His presentation focused on research into oncolytic viruses in connection with individualized cancer immunotherapy.

Symposium IOZK COLOGNE, 6 SEPTEMBER 2019

 

To mark the opening of the new GMP Laboratory at the IOZK we will host a scientific symposium with international speakers on the topic of »Immunotherapy in neuro-oncology«. More here: Homepage.

PROF. DR. SCHIRRMACHER, SYMPOSIUM KIEL

APRIL 2019

 

Prof. Dr. Schirrmacher opened the Kiel Oncology Network Symposium on tumour immunology. His presentation focused on research into oncolytic viruses in connection with individualized cancer immunotherapy.

Symposium IOZK KÖLN,

6. SEPTEMBER 2019

 

To mark the opening of the new GMP Laboratory at the IOZK we will host a scientific symposium with international speakers on the topic of »Immuno-therapy in neuro-oncology«.

More: see Homepage

The questions that we concern ourselves with arise from our everyday work in our practice. The search for answers aims to constantly continue the development of the active-specific immunotherapy against cancer and the swift implementation of their results into patient care

 

The purpose of the IOZK Foundation is to develop the scientific basis of immuno-oncological research and its translation into practice. The measures aim to promote the research of therapy options against cancer to enable a swift translation of results into patient care in accordance with regulatory guidelines.

 

Two T cells on a cancer cell, scanning electron microscopy, Steve Gschmeissner/Science Photo​

GERMAN MEDICAL AWARD, NovEMBER 17, 2020

 

The IOZK in person of Dr. Stücker was awarded in the category "INNOVATION - Procedures for Practices and Clinics: Department of Oncology". The German Medical Award is presented annually at the Medica Düsseldorf to pioneers in medicine and health care.

.

If you have further questions, please contact us:

 

telephone 0221 - 420 399 127

e-mail: stiftung@iozk.de

GERMAN MEDICAL AWARD, NovEMBER 17, 2020

 

The IOZK in person of Dr. Stücker was awarded in the category "INNOVATION - Procedures for Practices and Clinics: Oncology".

 

The German Medical Award is presented annually at the Medica Düsseldorf to pioneers in medicine and health care.

.

de   eng